BG99863A - Antagonists of fibrogenous receptor - Google Patents

Antagonists of fibrogenous receptor

Info

Publication number
BG99863A
BG99863A BG99863A BG9986395A BG99863A BG 99863 A BG99863 A BG 99863A BG 99863 A BG99863 A BG 99863A BG 9986395 A BG9986395 A BG 9986395A BG 99863 A BG99863 A BG 99863A
Authority
BG
Bulgaria
Prior art keywords
receptor
fibrogenous
antagonists
compounds
formula
Prior art date
Application number
BG99863A
Other languages
Bulgarian (bg)
Inventor
David Claremon
John Baldwin
Nigel Liverton
Ben Askew
Original Assignee
John Baldwin
Nigel Liverton
Ben Askew
Merck & Co. Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by John Baldwin, Nigel Liverton, Ben Askew, Merck & Co. Inc. filed Critical John Baldwin
Publication of BG99863A publication Critical patent/BG99863A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A61K38/166—Streptokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Съединенията притежават антагонистична активност по отношение на фибриногеновия рецептор. Те имат формула или напримерThe compounds have antagonistic activity with respect to the fibrinogen receptor. They have a formula or for example

BG99863A 1993-02-22 1995-08-15 Antagonists of fibrogenous receptor BG99863A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2051793A 1993-02-22 1993-02-22
PCT/US1994/001881 WO1994018981A1 (en) 1993-02-22 1994-02-22 Fibrinogen receptor antagonists

Publications (1)

Publication Number Publication Date
BG99863A true BG99863A (en) 1996-02-29

Family

ID=21799049

Family Applications (1)

Application Number Title Priority Date Filing Date
BG99863A BG99863A (en) 1993-02-22 1995-08-15 Antagonists of fibrogenous receptor

Country Status (15)

Country Link
EP (1) EP0684823A4 (en)
JP (1) JP3173792B2 (en)
KR (1) KR960700722A (en)
CN (1) CN1118139A (en)
AU (1) AU680240B2 (en)
BG (1) BG99863A (en)
CA (1) CA2155123A1 (en)
CZ (1) CZ210895A3 (en)
FI (1) FI953916A0 (en)
HU (1) HUT71796A (en)
NO (1) NO953270L (en)
NZ (1) NZ262664A (en)
PL (1) PL310386A1 (en)
SK (1) SK102495A3 (en)
WO (1) WO1994018981A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5849736A (en) * 1993-11-24 1998-12-15 The Dupont Merck Pharmaceutical Company Isoxazoline and isoxazole fibrinogen receptor antagonists
US5494921A (en) * 1994-09-16 1996-02-27 Merck & Co., Inc. Fibrinogen receptor antagonists
ZA963391B (en) * 1995-05-24 1997-10-29 Du Pont Merck Pharma Isoxazoline fibrinogen receptor antagonists.
CN1085980C (en) * 1995-08-30 2002-06-05 G·D·瑟尔公司 meta-guanidine, urea, thiourea or azacyclic amino benzoic acid derivatives as integrin antagonists
US6100423A (en) * 1995-08-30 2000-08-08 G. D. Searle & Co. Amino benzenepropanoic acid compounds and derivatives thereof
CA2233204A1 (en) 1995-09-29 1997-04-03 Joseph A. Jakubowski Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation
JP2000501105A (en) * 1995-12-22 2000-02-02 デュポン ファーマシューティカルズ カンパニー Novel integrin receptor antagonist
WO1997035579A1 (en) * 1996-03-27 1997-10-02 Merck & Co., Inc. A method for inhibiting clot formation
ES2271971T3 (en) * 1996-07-25 2007-04-16 Biogen Idec Ma Inc. INHIBITORS OF CELL ADHESION.
US5900414A (en) * 1996-08-29 1999-05-04 Merck & Co., Inc. Methods for administering integrin receptor antagonists
DE19653647A1 (en) * 1996-12-20 1998-06-25 Hoechst Ag Vitronectin receptor antagonists, their preparation and their use
CA2279927A1 (en) * 1997-02-06 1998-08-13 Merck & Co., Inc. Fibrinogen receptor antagonist prodrugs
US6214834B1 (en) 1997-03-28 2001-04-10 Dupont Pharmaceuticals Company Integrin inhibitor prodrugs
US6303625B1 (en) * 1998-07-27 2001-10-16 Ortho-Mcneil Pharmaceutical, Inc. Triazolopyridines for the treatment of thrombosis disorders
AU773227B2 (en) * 1999-07-28 2004-05-20 Aventis Pharmaceuticals Inc. Substituted oxoazaheterocyclyl compounds
CA2510298A1 (en) * 2002-12-20 2004-07-15 Pharmacia Corporation Acyclic pyrazole compounds
AU2007272009A1 (en) * 2006-07-12 2008-01-17 Syngenta Limited Triazolopyridine derivatives as herbicides
KR20100132999A (en) * 2008-04-04 2010-12-20 길리애드 사이언시즈, 인코포레이티드 Triazolopyridinone derivatives for use as stearoyl coa desaturase inhibitors
WO2010096722A1 (en) * 2009-02-20 2010-08-26 Takeda Pharmaceutical Company Limited 3-oxo-2, 3-dihydro- [1,2, 4] triazolo [4, 3-a]pyridines as soluble epoxide hydrolase (seh) inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5084466A (en) * 1989-01-31 1992-01-28 Hoffmann-La Roche Inc. Novel carboxamide pyridine compounds which have useful pharmaceutical utility
GB8913011D0 (en) * 1989-06-06 1989-07-26 Wellcome Found Anticonvulsant pyrazines
US5166154A (en) * 1989-10-17 1992-11-24 Boehringer Ingelheim Pharmaceuticals, Inc. Imidazo[1,2-a]piperazines
US5278161A (en) * 1990-06-28 1994-01-11 Hoffmann-La Roche Inc. Amino acid derivatives useful as renin inhibitors

Also Published As

Publication number Publication date
PL310386A1 (en) 1995-12-11
NZ262664A (en) 1997-04-24
JPH08507072A (en) 1996-07-30
CZ210895A3 (en) 1996-02-14
JP3173792B2 (en) 2001-06-04
EP0684823A4 (en) 1997-07-09
KR960700722A (en) 1996-02-24
NO953270D0 (en) 1995-08-21
AU680240B2 (en) 1997-07-24
HUT71796A (en) 1996-02-28
FI953916A (en) 1995-08-21
FI953916A0 (en) 1995-08-21
AU6246594A (en) 1994-09-14
CN1118139A (en) 1996-03-06
NO953270L (en) 1995-10-19
CA2155123A1 (en) 1994-09-01
EP0684823A1 (en) 1995-12-06
WO1994018981A1 (en) 1994-09-01
HU9502028D0 (en) 1995-09-28
SK102495A3 (en) 1997-01-08

Similar Documents

Publication Publication Date Title
BG99863A (en) Antagonists of fibrogenous receptor
DE69325130D1 (en) N-SULFONYL-2-OXOINDOL DERIVATIVES WITH AN AFFINITY FOR THE VASOPRESSIN AND / OR OCYTOCIN RECEPTORS
EA200000098A1 (en) 4-AMINOPIRROL (3,2-d) Pyrimidine as antagonists of the neuropeptide Y neuropeptide
DE69207351D1 (en) Fibrinogen receptor antagonists
FI903331A0 (en) KINAZOLINONER SUBSTITUERADE, VILKA AER ANVAENDBARA SOM ANGIOTENSIN-II-ANTAGONISTER.
MX9101311A (en) FIBRINOGEN RECEPTOR ANTAGONISTS
DE69130614T2 (en) HERBICIDAL, SUBSTITUTED ARYL-HALOALKYLPYRAZOLE
ATE293609T1 (en) ANTIBACTERIALLY EFFECTIVE OXAZOLIDINONE WITH A THIOCARBONYL FUNCTIONALITY
DE69127791D1 (en) Diazabicyclononyl derivatives as 5-HT3 receptor antagonists
MX9205678A (en) HETEROARILAMINES AS NEW INHIBITORS OF ACETYLCHOLINESTERASE.
ATE135004T1 (en) SULFONYL UREAS AS HERBICIDES
SE9702773D0 (en) Novel compounds
FI921345A0 (en) PIPERIDINDERIVAT.
ATE198202T1 (en) FIBRINOGEN RECEPTOR ANTAGONISTS
DE3585980D1 (en) HYDRAZINE DERIVATIVES AND THEIR USE.
FI863836A0 (en) KINOLINDERIVAT.
ES2156255T3 (en) PROCEDURE FOR PREPARING ANTAGONISTS OF THE FIBRINOGEN RECEIVER.
MX9300742A (en) QUINOLINE DERIVATIVES SUBSTITUTED WITH BIPHENYL AND PHARMACEUTICAL COMPOSITION CONTAINING THEM.
ES2099879T3 (en) 5-OXO-DIBENZO (A, D) CICLOHEPTA-1,4-DIENOS AND ITS USE AS RETROVIRAL AGENTS.
DK0566175T3 (en) 3,4-diaryl- (5H) -furan-2-one based compounds with fungicidal activity
KR950700305A (en) Azabicyclo compounds as calcium channel antagonists
ES2004215A6 (en) Trifluoromethyl substituted tetracyclic quinazolin-ones having tranquilizing activity
SU1610823A1 (en) S-TRET-BUTYLTIURONIUM BROMIDE possessing anti-ischemic activity
SU1786802A1 (en) 2,4-DIMETHYL-9-OXYPYRIDE [1,2-a] PYRIMIDININE CHLORIDE possessing anti-receptor activity
SU1746666A1 (en) SUBSTITUTED 3-AMINOMETHYLENE PYRROLIDIN-2,4-DIONA, possessing anti-traffic activity